GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Verano Holdings Corp (OTCPK:VRNOF) » Definitions » COGS-to-Revenue

Verano Holdings (Verano Holdings) COGS-to-Revenue : 0.50 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Verano Holdings COGS-to-Revenue?

Verano Holdings's Cost of Goods Sold for the three months ended in Dec. 2023 was $119.6 Mil. Its Revenue for the three months ended in Dec. 2023 was $237.2 Mil.

Verano Holdings's COGS to Revenue for the three months ended in Dec. 2023 was 0.50.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Verano Holdings's Gross Margin % for the three months ended in Dec. 2023 was 49.59%.


Verano Holdings COGS-to-Revenue Historical Data

The historical data trend for Verano Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verano Holdings COGS-to-Revenue Chart

Verano Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- 0.41 0.55 0.52 0.49

Verano Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.52 0.51 0.45 0.50

Verano Holdings COGS-to-Revenue Calculation

Verano Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=463.246 / 938.452
=0.49

Verano Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=119.578 / 237.189
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verano Holdings  (OTCPK:VRNOF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Verano Holdings's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 119.578 / 237.189
=49.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Verano Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Verano Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Verano Holdings (Verano Holdings) Business Description

Traded in Other Exchanges
Address
415 North Dearborn Street, 4th Floor, Chicago, IL, USA, 60654
Verano Holdings Corp is a vertically integrated multi?state cannabis operator in the United States. The company derives its revenues from its wholesale business and its retail dispensary chains. The retail business includes the design, build-out and operation of branded dispensaries in both medical and adult-use markets. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV.